21-Oct-2014 - Venom from a Brazilian Wandering Spider that ‘wandered’ into a UK household’s shopping basket could treat erectile dysfunction, according to scientists, in one example of drug ingredients being sourced from nature.
20-Oct-2014 - Analysts predicting a second wave of global API hubs say it will be hard for manufacturers in Latin America, Ukraine and Taiwan to avoid the pitfalls that stymied former high growth sectors in Asia.
15-Oct-2014 - Drug active ingredients in food supplements are Europe’s real falsified medicines problem according to the head of AIFA’s counterfeit prevention team.
14-Oct-2014 - 'Excipient compound' monographs should be included in the European Pharmacopoeia according to IPEC, which argues they would help manufacturers and promote acceptance of the standards outside Europe.
13-Oct-2014 - The auditing company, SGS, recently certified that Capsugel’s manufacturing sites in Colmar, France and Bornem, Belgium meet Good Manufacturing Practice (GMP) standards set by EXCiPACT for pharmaceutical excipients manufacturing.
08-Oct-2014 - [View the story "Pharma industry goes to Paris" on Storify]
08-Oct-2014 - The sharing of audit reports for active pharmaceutical ingredients (APIs) is essential in order to help avert the global decline in quality, according to Hovione’s CEO.
07-Oct-2014 - Making drugs generates a huge amount of waste but industry is showing signs of cleaning up its act according to Paul Anastas, the Yale scientist who coined the phrase "green chemistry."
01-Oct-2014 - Making active pharmaceutical ingredients (API) is a dirty business and you’d have to be pretty green to believe claims drug industry 'demand' will create a $100bn market for environmentally-friendly production methods by 2020.
01-Oct-2014 - The acquisition of Shasun Pharmaceuticals will add API production and contracting services to Strides Arcolab, and according to Shasun’s CEO no jobs will be lost.
30-Sep-2014 - Consort Medical will buy UK contractor Aesica for £230m from Silverfleet Capital in a deal announced today.
23-Sep-2014 - Hikma has opened a new API facility in Jordan to support its oncology pipeline.
22-Sep-2014 - The $17bn (€13.2bn) acquisition of Sigma-Aldrich is “not just a milestone but a quantum leap” for Merck KGaA, the firm says.
18-Sep-2014 - Scientists looking to solve the looming threat of antimicrobial resistance have discovered an antibiotic in the vagina.
18-Sep-2014 - After much discussion and some confusion , the ICH’s (International Conference on Harmonization) Q3D guideline , which will govern elemental impurities in final drug products, is expected to be finalized at the end of this month.
16-Sep-2014 - Almac has teamed up with Welsh Academics and industrial chemistry firm Hockley International to develop enzymes capable of making drug intermediates more quickly.
16-Sep-2014 - Mannkind says Sanofi could become a second API supplier for its recently approved inhalable insulin drug Afrezza following its commercialisation partnership last month.
15-Sep-2014 - Ireland once was a drug making nexus,Making meds sold from Cairo to Texas.But with key patents gone,Firms are keen to move on,And a new Limerick tech hub reflects this, says director.
08-Sep-2014 - Synthon has consolidated its Czech API capabilities through the sale of a laboratory and pilot scale plant in Prague to CRO Mercachem.
08-Sep-2014 - Chemicals firm Evonik has expanded its capacity in Japan to cope with high demands for specialty silica, used in various drugmaking operations.
08-Sep-2014 - The International Society for Pharmaceutical Engineering (ISPE) last week offered up a preview to its plan to help manufacturers avoid or mitigate drug shortages due to manufacturing or quality issues.
04-Sep-2014 - Xellia has agreed to invest $100m in equipment, retain staff and create 40 full time jobs at the plant it bought in Raleigh, North Carolina in return for business incentives.
03-Sep-2014 - Novo Nordisk has scrapped all its inflammatory disease therapy development programmes, cutting 400 jobs.
02-Sep-2014 - A German biobank has made stem cells available to active pharmaceutical ingredient (API) firms this week in a bid to support industry drug development efforts.
29-Aug-2014 - Biopharmaceutical firm Merck Serono will make small molecule drugs at the new plant it is building in China according to a company spokeswoman, who told us the firm will supply both local and international markets.
The sharing of audit reports for active pharmaceutical ingredients (APIs) is essential in order to help avert...
dispatches from technopharm
Flexible inkjet printing and personalized medicine will grow the market for orodispersible delivery technologies according to experts...
Pre CPhI Special
The world is getting larger, at least it is in terms of the pharmaceutical industry, according to...
Pre CPhI Special
Making active pharmaceutical ingredients (API) is a dirty business and you’d have to be pretty green to...
The Pharma industry has responded to the Ebola crisis in West Africa with developmental vaccines and aid...
The US National Institutes of Health (NIH) is collecting photos of pills and tablet in a database...